ECT, glaucoma, and prolonged apnea.
Chessen
D H
DH
Department of Psychiatry, Harvard Medical School, Massachusetts Mental Health Center, USA.
Geha
D G
DG
Salzman
C
C
D000368:Aged; D001049:Apnea / Q000139:chemically induced / Q000209:etiology* / Q000503:physiopathology; D002091:Butyrylcholinesterase / Q000097:blood / Q000172:deficiency; D002800:Cholinesterase Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D003863:Depression / Q000523:psychology* / Q000628:therapy*; D004456:Echothiophate Iodide / Q000009:adverse effects* / Q000627:therapeutic use; D004565:Electroconvulsive Therapy / Q000009:adverse effects*; D005260:Female; D005901:Glaucoma / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D011595:Psychomotor Agitation / Q000209:etiology; D012720:Severity of Illness Index; D013997:Time Factors
D002800:Cholinesterase Inhibitors; D004456:Echothiophate Iodide; D002091:Butyrylcholinesterase